vs
Side-by-side financial comparison of Bandwidth Inc. (BAND) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
Bandwidth Inc. is the larger business by last-quarter revenue ($208.8M vs $164.7M, roughly 1.3× PTC THERAPEUTICS, INC.). Bandwidth Inc. runs the higher net margin — 1.9% vs -82.0%, a 83.9% gap on every dollar of revenue. On growth, Bandwidth Inc. posted the faster year-over-year revenue change (20.1% vs -22.7%). Bandwidth Inc. produced more free cash flow last quarter ($-1.0M vs $-36.6M). Over the past eight quarters, Bandwidth Inc.'s revenue compounded faster (9.7% CAGR vs -11.5%).
Bandwidth Inc. is a communications platform as a service company. It sells software application programming interfaces for voice, text messaging and emergency services, using its own global IP voice network.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
BAND vs PTCT — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $208.8M | $164.7M |
| Net Profit | $4.0M | $-135.0M |
| Gross Margin | 37.3% | — |
| Operating Margin | 60.5% | -43.3% |
| Net Margin | 1.9% | -82.0% |
| Revenue YoY | 20.1% | -22.7% |
| Net Profit YoY | 200.0% | -104.8% |
| EPS (diluted) | $-0.08 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $208.8M | — | ||
| Q4 25 | $207.7M | $164.7M | ||
| Q3 25 | $191.9M | $211.0M | ||
| Q2 25 | $180.0M | $178.9M | ||
| Q1 25 | $174.2M | $1.2B | ||
| Q4 24 | $210.0M | $213.2M | ||
| Q3 24 | $193.9M | $196.8M | ||
| Q2 24 | $173.6M | $186.7M |
| Q1 26 | $4.0M | — | ||
| Q4 25 | — | $-135.0M | ||
| Q3 25 | $-1.2M | $15.9M | ||
| Q2 25 | $-4.9M | $-64.8M | ||
| Q1 25 | $-3.7M | $866.6M | ||
| Q4 24 | — | $-65.9M | ||
| Q3 24 | $413.0K | $-106.7M | ||
| Q2 24 | $4.1M | $-99.2M |
| Q1 26 | 37.3% | — | ||
| Q4 25 | 37.6% | — | ||
| Q3 25 | 38.5% | — | ||
| Q2 25 | 39.8% | — | ||
| Q1 25 | 41.0% | — | ||
| Q4 24 | 36.4% | — | ||
| Q3 24 | 37.7% | — | ||
| Q2 24 | 37.3% | — |
| Q1 26 | 60.5% | — | ||
| Q4 25 | -1.9% | -43.3% | ||
| Q3 25 | -1.0% | 1.4% | ||
| Q2 25 | -2.1% | -19.5% | ||
| Q1 25 | -2.7% | 82.5% | ||
| Q4 24 | -1.3% | -76.2% | ||
| Q3 24 | -0.5% | -27.7% | ||
| Q2 24 | -3.5% | -21.5% |
| Q1 26 | 1.9% | — | ||
| Q4 25 | — | -82.0% | ||
| Q3 25 | -0.6% | 7.5% | ||
| Q2 25 | -2.7% | -36.3% | ||
| Q1 25 | -2.1% | 73.7% | ||
| Q4 24 | — | -30.9% | ||
| Q3 24 | 0.2% | -54.2% | ||
| Q2 24 | 2.3% | -53.1% |
| Q1 26 | $-0.08 | — | ||
| Q4 25 | $-0.10 | $-1.63 | ||
| Q3 25 | $-0.04 | $0.20 | ||
| Q2 25 | $-0.16 | $-0.83 | ||
| Q1 25 | $-0.13 | $10.04 | ||
| Q4 24 | $0.27 | $-0.85 | ||
| Q3 24 | $0.01 | $-1.39 | ||
| Q2 24 | $-0.17 | $-1.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $47.3M | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $405.7M | $-205.3M |
| Total Assets | $984.2M | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $47.3M | — | ||
| Q4 25 | $111.3M | $1.9B | ||
| Q3 25 | $80.4M | $1.7B | ||
| Q2 25 | $68.1M | $2.0B | ||
| Q1 25 | $41.7M | $2.0B | ||
| Q4 24 | $83.8M | $1.1B | ||
| Q3 24 | $79.9M | $1.0B | ||
| Q2 24 | $76.4M | $1.1B |
| Q1 26 | $405.7M | — | ||
| Q4 25 | $400.0M | $-205.3M | ||
| Q3 25 | $392.7M | $-155.8M | ||
| Q2 25 | $384.5M | $-206.5M | ||
| Q1 25 | $345.4M | $-185.8M | ||
| Q4 24 | $312.5M | $-1.1B | ||
| Q3 24 | $336.6M | $-1.1B | ||
| Q2 24 | $307.4M | $-980.2M |
| Q1 26 | $984.2M | — | ||
| Q4 25 | $1.1B | $2.9B | ||
| Q3 25 | $1.0B | $2.6B | ||
| Q2 25 | $1.0B | $2.6B | ||
| Q1 25 | $964.4M | $2.7B | ||
| Q4 24 | $989.2M | $1.7B | ||
| Q3 24 | $1.0B | $1.8B | ||
| Q2 24 | $1.0B | $1.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-34.3M |
| Free Cash FlowOCF − Capex | $-1.0M | $-36.6M |
| FCF MarginFCF / Revenue | -0.5% | -22.3% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $38.6M | $-34.3M | ||
| Q3 25 | $22.2M | $-66.3M | ||
| Q2 25 | $31.7M | $-58.3M | ||
| Q1 25 | $-3.1M | $870.1M | ||
| Q4 24 | $36.5M | $-30.0M | ||
| Q3 24 | $20.5M | $-77.0M | ||
| Q2 24 | $24.4M | $-71.5M |
| Q1 26 | $-1.0M | — | ||
| Q4 25 | — | $-36.6M | ||
| Q3 25 | — | $-69.7M | ||
| Q2 25 | — | $-59.6M | ||
| Q1 25 | — | $868.4M | ||
| Q4 24 | — | $-33.8M | ||
| Q3 24 | — | $-77.5M | ||
| Q2 24 | — | $-78.8M |
| Q1 26 | -0.5% | — | ||
| Q4 25 | — | -22.3% | ||
| Q3 25 | — | -33.1% | ||
| Q2 25 | — | -33.3% | ||
| Q1 25 | — | 73.8% | ||
| Q4 24 | — | -15.8% | ||
| Q3 24 | — | -39.4% | ||
| Q2 24 | — | -42.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 4.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | -4.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | — | ||
| Q3 24 | 49.55× | — | ||
| Q2 24 | 6.03× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
